These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2551132)
21. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist. Maria B; Stampf F; Goepp A; Ulmann A Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966 [TBL] [Abstract][Full Text] [Related]
22. Clinical trial on termination of early pregnancy with RU486 in combination with prostaglandin. Wu S; Gao J; Wu Y; Wu M; Fan H; Yao G; Zheng S; Wang P; Du M; Huang Z Contraception; 1992 Sep; 46(3):203-10. PubMed ID: 1451516 [TBL] [Abstract][Full Text] [Related]
23. Trophoblastic and decidual response to RU486: effects on human chorionic gonadotrophin, human placental lactogen, prolactin and pregnancy-associated plasma protein-A production in vitro. Bischof P; Sizonenko MT; Herrmann WL Hum Reprod; 1986 Jan; 1(1):3-6. PubMed ID: 2458379 [TBL] [Abstract][Full Text] [Related]
24. Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II. McKeown KJ; Challis JR; Small C; Adamson L; Bocking AD; Fraser M; Rurak D; Riggs KW; Lye SJ Biol Reprod; 2000 Dec; 63(6):1899-904. PubMed ID: 11090463 [TBL] [Abstract][Full Text] [Related]
25. Fertility control in women: results with RU 486 by the end of 1985. Baulieu E J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366 [TBL] [Abstract][Full Text] [Related]
26. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013 [TBL] [Abstract][Full Text] [Related]
27. The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy. Sitruk-Ware R; Thalabard JC; De Plunkett TL; Lewin F; Epelboin S; Mowszowicz I; Yaneva H; Tournaire M; Chavinie J; Mauvais-Jarvis P Contraception; 1990 Mar; 41(3):221-43. PubMed ID: 2323217 [TBL] [Abstract][Full Text] [Related]
28. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625 [TBL] [Abstract][Full Text] [Related]
29. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. van Haarst AD; Oitzl MS; Workel JO; de Kloet ER Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366 [TBL] [Abstract][Full Text] [Related]
30. Circulating levels of placental protein 14 and progesterone following Mifepristone (RU38486) and Gemeprost for termination of first trimester pregnancy. Howell RJ; Olajide F; Teisner B; Grudzinskas G; Chard T Fertil Steril; 1989 Jul; 52(1):66-8. PubMed ID: 2744189 [TBL] [Abstract][Full Text] [Related]
31. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Bygdeman M; Swahn ML Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605 [TBL] [Abstract][Full Text] [Related]
34. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Martin CW; Brown AH; Baird DT Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264 [TBL] [Abstract][Full Text] [Related]
35. [Abortion induced by RU 486: importance of its combination with a prostaglandin derivative]. Dubois C; Ulmann A; Aubeny E; Elia D; Jourdan MC; Van den Bosch MC; Leton M; Baulieu EE C R Acad Sci III; 1988; 306(2):57-61. PubMed ID: 3126988 [TBL] [Abstract][Full Text] [Related]
36. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [TBL] [Abstract][Full Text] [Related]
37. Action of progesterone and RU38486 on protein synthesis in rat placenta. Ogle TF; Nosek TM; Mills TM Adv Exp Med Biol; 1987; 219():689-92. PubMed ID: 3434449 [No Abstract] [Full Text] [Related]
38. Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity. Heikinheimo O; Raivio T; Honkanen H; Ranta S; Jänne OA J Clin Endocrinol Metab; 2003 Jan; 88(1):323-6. PubMed ID: 12519872 [TBL] [Abstract][Full Text] [Related]
39. The use of anti-progesterones as a medical IUD. Nieman LK; Loriaux DL Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821 [TBL] [Abstract][Full Text] [Related]
40. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). el-Refaey H; Hinshaw K; Templeton A Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]